The Biomedical Research Foundation of the Academy of Athens is a leader in clinical and tissue proteomics. It is a non-profit institute dedicated to understanding, treating, and preventing human ailments through biomedical research. It has gained prominence as one of the major institutes for biomedical research in Greece, and researchers from the institute have been awarded multiple competitive grants including Marie Curie fellowships and EC research grants.

Within sysVASC, the Biomedical Research Foundation will contribute tissue proteomics analysis (using MALDI MS imaging), perform verification of selected findings, along with inference assays.


© biolution GmbH

Dr. Antonia Vlahou

Antonia Vlahou is group leader and co-director of the Proteomics Research Unit at the Biomedical Research Foundation. She has worked extensively on clinical proteomics investigations by the use of a combination of non-targeted (mass spectrometry-based) and targeted (ELISA-based) proteomics methodologies. Antonia Vlahou has coordinated the European Kidney and Urine Proteomics COST Action (2008-2012) and is currently WP Leader in the FP7 project Neurinox, among others.




1 Zoidakis, J., et al. (2012). Profilin 1 is a Potential Biomarker for Bladder Cancer Aggressiveness Mo Cell Proteomics.1, Mll l.009449.

2 Makridakis, M., et al. (2010). JAnalysis of Secreted Proteins for the Study of Bladder Cancer Cell Aggressiveness Proteome Res. 9, 3243-59.

3 Bitsika, V., et al. (2012). Human Amniotic Fluid-Derived Mesenchymal Stem Cells as Therapeutic Vehicles: A Novel Approach for the Treatment of Bladder Cancer. Stem Cells Dev. 21, 1097-111.

By continuing to use the site, you agree to the use of cookies. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.